跳至主要内容
临床试验/EUCTR2004-002180-24-GB
EUCTR2004-002180-24-GB进行中(未招募)1 期

Prospective randomised double blind comparative study of cinnarizine versus placebo as prophylactic anti-travel sickness therapy in patients undergoing dy-case gynaecological surgery. - Cinnarizine Study

Swindon & Marlborough NHS Trust0 个研究点目标入组 272 人开始时间: 2005年3月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
272

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 1. Female patients
  • 2. Undergoing day case gynaecological surgery
  • 3. Aged 18-60 years
  • 4. ASA 1 & 2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Those who are unable to give informed consent.
  • 2. Patients with gastrointestinal disease.
  • 3. Patients with hepatic or renal disease.
  • 4. Pregnant or lactating patients.
  • 5. Those patients with known or suspected adverse reactions to the study drugs.
  • 6. Patients undergoing therapeutic termination of pregnancy.
  • 7. Patients undergoing surgery for miscarriage.
  • 8. Obese patients (BMI>30)
  • 9. Patients suffering from pre-operative nausea or vomiting
  • 10. Patients receiving current oral or intramuscular steroid therapy.
  • 11. Patients suffering severe acute anxiety reactions.
  • 12. Patients receiving other anti-emetic drugs

研究者

发起方
Swindon & Marlborough NHS Trust

相似试验